EXAS MEXC RealStocks
Own real EXAS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 03:50:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Exact Sciences Corp. (EXAS) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Exact Sciences Corp. (EXAS) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, EXAS traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Exact Sciences Corp. (EXAS) moved from $103.37 to $104.91, representing a gain of 1.49% ($1.54).
The stock traded between $103.25 and $104.98 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 4.78 million shares, up versus the previous seven-day period, indicating higher trading activity.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 7,200 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Exact Sciences Corp. (EXAS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to EXAS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between EXAS shares and USD.
EXAS Shares to USD
1.00 EXAS shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.